These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27712039)

  • 1. Efficacy of topical flutamide in the treatment of melasma.
    Bagherani N
    Dermatol Ther; 2016 Sep; 29(5):297. PubMed ID: 27712039
    [No Abstract]   [Full Text] [Related]  

  • 2. The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial.
    Adalatkhah H; Sadeghi-Bazargani H
    Drug Des Devel Ther; 2015; 9():4219-25. PubMed ID: 26345129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is topical zinc effective in the treatment of melasma? A double-blind randomized comparative study.
    Yousefi A; Khani Khoozani Z; Zakerzadeh Forooshani S; Omrani N; Moini AM; Eskandari Y
    Dermatol Surg; 2014 Jan; 40(1):33-7. PubMed ID: 24237751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Evaluation of a 4% Hydroquinone + 1% Retinol Treatment Regimen for Improving Melasma and Photodamage in Fitzpatrick Skin Types III-VI.
    Rendon MI; Barkovic S
    J Drugs Dermatol; 2016 Nov; 15(11):1435-1441. PubMed ID: 28095558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective Tyrosinase Inhibition by Thiamidol Results in Significant Improvement of Mild to Moderate Melasma.
    Arrowitz C; Schoelermann AM; Mann T; Jiang LI; Weber T; Kolbe L
    J Invest Dermatol; 2019 Aug; 139(8):1691-1698.e6. PubMed ID: 30825454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating epidermal melasma with a 4% hydroquinone skin care system plus tretinoin cream 0.025%.
    Grimes P; Watson J
    Cutis; 2013 Jan; 91(1):47-54. PubMed ID: 23461059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel triple combination in treatment of melasma: Significant outcome with far less actives.
    Pekmezci E
    J Cosmet Dermatol; 2019 Dec; 18(6):1700-1704. PubMed ID: 30920111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigator-Blinded, Single-Center Study to Evaluate the Efficacy and Tolerability of a 4% Hydroquinone Skin Care System Plus 0.02% Tretinoin Cream in Mild-to-Moderate Melasma and Photodamage.
    Rendon M; Dryer L
    J Drugs Dermatol; 2016 Apr; 15(4):466-75. PubMed ID: 27050702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical Treatments for Melasma: A Systematic Review of Randomized Controlled Trials.
    Austin E; Nguyen JK; Jagdeo J
    J Drugs Dermatol; 2019 Nov; 18(11):. PubMed ID: 31741361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of therapeutic effects of conventional and liposomal form of 4% topical hydroquinone in patients with melasma.
    Taghavi F; Banihashemi M; Zabolinejad N; Salehi M; Jaafari MR; Marhamati H; Golnouri F; Dorri M
    J Cosmet Dermatol; 2019 Jun; 18(3):870-873. PubMed ID: 30105847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel skin brightener used as monotherapy for moderate melasma in skin of color.
    Grimes PE
    J Drugs Dermatol; 2014 Mar; 13(3):364-6. PubMed ID: 24595584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin lightening agents - Use or abuse? - A retrospective analysis of the topical preparations used by melasma patients of darker skin types.
    Kandhari R; Khunger N
    Indian J Dermatol Venereol Leprol; 2013; 79(5):701-2. PubMed ID: 23974587
    [No Abstract]   [Full Text] [Related]  

  • 13. The Therapeutic Use of Antioxidants for Melasma.
    Babbush KM; Babbush RA; Khachemoune A
    J Drugs Dermatol; 2020 Aug; 19(8):788-792. PubMed ID: 32845595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability on melasma of a topical cosmetic product acting on melanocytes, fibroblasts and endothelial cells: a randomized comparative trial against 4% hydroquinone.
    Bronzina E; Clement A; Marie B; Fook Chong KT; Faure P; Passeron T
    J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):897-903. PubMed ID: 31858658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between Intralesional Triamcinolone and Kligman's Formula in Treatment of Melasma.
    Eshghi G; Khezrian L; Esna Ashari F
    Acta Med Iran; 2016 Jan; 54(1):67-71. PubMed ID: 26853293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of hydroquinone-resistant melasma using topical methimazole.
    Malek J; Chedraoui A; Nikolic D; Barouti N; Ghosn S; Abbas O
    Dermatol Ther; 2013; 26(1):69-72. PubMed ID: 23384022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial.
    Khemis A; Kaiafa A; Queille-Roussel C; Duteil L; Ortonne JP
    Br J Dermatol; 2007 May; 156(5):997-1004. PubMed ID: 17388924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Tranexamic Acid in Melasma: A Meta-analysis and Systematic Review.
    Kim HJ; Moon SH; Cho SH; Lee JD; Kim HS
    Acta Derm Venereol; 2017 Jul; 97(7):776-781. PubMed ID: 28374042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new proprietary gel containing glabridin, andrographolide, and apolactoferrin improves the appearance of epidermal melasma in adult women: A 6-month pilot, uncontrolled open-label study.
    Cantelli M; Ferrillo M; Donnarumma M; Emanuele E; Fabbrocini G
    J Cosmet Dermatol; 2020 Jun; 19(6):1395-1398. PubMed ID: 31541594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of melasma using tranexamic acid: what's known and what's next.
    Sheu SL
    Cutis; 2018 Feb; 101(2):E7-E8. PubMed ID: 29554171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.